Related Experiment Video
Updated: Nov 10, 2025

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Weaning from Impella and mobilization of Impella patients
Letizia Fausta Bertoldi1, Andrea Montisci2, Clement Delmas3
1Cardio Center, Humanitas Clinical and Research Hospital-IRCCS, via Manzoni 56, 20089 Rozzano (MI), Italy.
Abstract:
Weaning of patients from Impella is complex and includes evaluation of the underlying disease, which is essential for estimating the potential for heart recovery. Monitoring during the weaning phase with echocardiography and pulmonary artery catheters will be discussed, as well as the use of intravenous and oral heart failure drugs. Patients who are candidates for weaning must be stable, without inotropes, and must have recovered from acute end-organ damage. Coronary artery disease and valvular heart diseases should be appropriately addressed before weaning to take the maximum advantage of haemodynamic stability provided by the support and to maximize the possibility of weaning. Tips and tricks for the mobilization of Impella patients will also be discussed.

